Related Experiment Video
Updated: Apr 12, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
Multidisciplinary management of pancreatic cancer
1Presented by Margaret A. Tempero, MD, Director of the University of California, San Francisco, Pancreas Center; Professor of Medicine at the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; and Editor-in-Chief of JNCCN-Journal of the National Comprehensive Cancer Network.
Abstract:
Pancreatic cancer remains a vexing treatment challenge, with a cure rate that remains just 7%. Two effective regimens--gemcitabine/nab-paclitaxel and FOLFIRINOX--have improved outcomes and are being used earlier in the disease. However, meaningful differences in outcomes may not be realized without novel strategies. Targeting of the immune system is an active area of research.
More Related Videos
13:56Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
08:12Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
Published on: February 2, 2022
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...